Authors:
VANGIJN R
HUININK WWT
RODENHUIS S
VERMORKEN JB
VANTELLINGEN O
ROSING H
VANWARMERDAM LJC
ALAKL MK
BEIJNEN JH
Citation: R. Vangijn et al., PHASE-I AND PHARMACOLOGICAL STUDY WITH THE NOVEL TOPOISOMERASE I II INHIBITOR INTOPLICINE ADMINISTERED AS A 24-HOUR INFUSION/, Annals of oncology, 9, 1998, pp. 251-251
Authors:
VANGIJN R
HERBEN VMM
HILLEBRAND MJX
HUININK WWT
BULT A
BEIJNEN JH
Citation: R. Vangijn et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF THE INVESTIGATIONAL ANTICANCER DRUG 9-AMINOCAMPTOTHECIN, AS THE LACTONE FORM AND AS THETOTAL OF THE LACTONE AND THE HYDROXYCARBOXYLATE FORMS, IN MICRO-VOLUMES OF HUMAN PLASMA, Journal of pharmaceutical and biomedical analysis, 17(8), 1998, pp. 1257-1265
Authors:
ROSING H
VANGIJN R
HUININK WWT
BEIJNEN JH
Citation: H. Rosing et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF THE CARDIOPROTECTIVE AGENT DEXRAZOXANE IN HUMAN PLASMA AND URINE, Journal of liquid chromatography & related technologies, 20(4), 1997, pp. 583-601
Authors:
VANGIJN R
VANTELLINGEN O
DECLIPPELEIR JJM
HILLEBRAND MJX
BOVEN E
VERMORKEN JB
HUININK WWT
SCHWERTZ S
GRAF P
BEIJNEN JH
Citation: R. Vangijn et al., ANALYTICAL PROCEDURE FOR THE DETERMINATION OF THE NEW ANTITUMOR DRUG N-BENZOYLSTAUROSPORINE AND 3 POTENTIAL METABOLITES IN HUMAN PLASMA BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical applications, 667(2), 1995, pp. 269-276
Authors:
VANGIJN R
HAVIK E
BOVEN E
VERMORKEN JB
HUININK WWT
VANTELLINGEN O
BEIJNEN JH
Citation: R. Vangijn et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF THE NEW ANTITUMORDRUG N-BENZOYLSTAUROSPORINE (CGP-41-251) AND 4 POTENTIAL METABOLITES IN MICRO-VOLUMES OF PLASMA, Journal of pharmaceutical and biomedical analysis, 14(1-2), 1995, pp. 165-174
Authors:
BURGER DM
VANDIJK EA
VANGIJN R
BEIJNEN JH
Citation: Dm. Burger et al., EFFECT OF HEAT-TREATMENT OF POTENTIALLY INFECTED BLOOD-SAMPLES ON THERAPEUTIC DRUG-MONITORING OF SELECTED DRUGS, The Annals of pharmacotherapy, 27(7-8), 1993, pp. 887-888
Authors:
VANGIJN R
KUIJS S
ROSING H
DUBBELMAN AC
VANTELLINGEN O
HUININK WWT
PINEDO HM
BEIJNEN JH
Citation: R. Vangijn et al., DETERMINATION OF INTOPLICINE, A NEW ANTITUMOR DRUG, IN HUMAN FECES BYNORMAL-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCEDETECTION, Journal of pharmaceutical and biomedical analysis, 11(11-12), 1993, pp. 1345-1348
Authors:
VANGIJN R
DEGRAAFFTEULEN MJA
VANTELLINGEN O
BEIJNEN JH
Citation: R. Vangijn et al., CHEMICAL-STABILITY OF THE NEW ANTITUMOR AGENT INTOPLICINE IN INFUSIONFLUIDS, Journal of pharmaceutical and biomedical analysis, 11(11-12), 1993, pp. 1353-1356
Authors:
VANGIJN R
ROSING H
HUININK WWT
VANTELLINGEN O
VERMORKEN JB
LIEFTING AJM
BRUNO R
PINEDO HM
BEIJNEN JH
Citation: R. Vangijn et al., DETERMINATION OF INTOPLICINE, A NEW ANTITUMOR DRUG, IN HUMAN WHOLE-BLOOD AND PLASMA BY NORMAL-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION, Journal of chromatography. Biomedical applications, 614(2), 1993, pp. 299-306
Citation: Jh. Beijnen et R. Vangijn, CHEMICAL-STABILITY OF THE CARDIOPROTECTIVE AGENT ICRF-187 IN INFUSIONFLUIDS, Journal of parenteral science and technology, 47(4), 1993, pp. 166-171